Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (10)

2023

  1. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

    Quality of Life Research, Vol. 32, Núm. 4, pp. 989-1003

2021

  1. Factors that Influence Treatment Delay for Patients with Breast Cancer

    Annals of Surgical Oncology, Vol. 28, Núm. 7, pp. 3714-3721

2020

  1. What accounts for physical activity during pregnancy? A study on the sociodemographic predictors of self-reported and objectively assessed physical activity during the 1st and 2nd trimesters of pregnancy

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 7

2018

  1. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)

    International Journal of Colorectal Disease, Vol. 33, Núm. 2, pp. 241-249

2016

  1. Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile

    Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428

2015

  1. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

    Oncotarget, Vol. 6, Núm. 42, pp. 44254-44273

2013

  1. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: Results from the GEICAM/2003-02 study

    Journal of Clinical Oncology

2012

  1. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers

    BMC Medical Genomics, Vol. 5

2010

  1. Current perspectives of treatment of ductal carcinoma in situ

    Cancer Treatment Reviews, Vol. 36, Núm. 7, pp. 507-517

  2. Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))

    Clinical and Translational Oncology